← Open Payments lookup

HEATHER POPHAM: Open Payments

NPI 1093086985 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,094 in 46 payments from 21 companies in 2025. Trend: 2023 $2,577 · 2024 $1,635 · 2025 $1,094

Food & beverage: $1,094
CompanyPaymentsAmount
TG Therapeutics, Inc.4$140
Neurocrine BioSciences, Inc.5$130
Novartis Pharmaceuticals Corporation4$112
UCB, Inc.3$88
Alkermes, Inc.3$78
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$75
Amneal Pharmaceuticals LLC3$72
SK Life Science, Inc.2$56
Neos Therapeutics, LP3$55
E.R. Squibb & Sons, L.L.C.2$47

Products named: BRIUMVI, INGREZZA, KESIMPTA, ARISTADA, CAPLYTA, CREXONT, Nayzilam, Adzenys XR-ODT.

Industry payments across MO — which companies pay providers there.